Asthma treatment goals currently focus on symptom and exacerbation control rather than
remission. Remission is not identical to cure, but is a step closer. This review considers the …

With novel therapies in development, there is an opportunity to consider asthma remission
as a treatment goal. In this Rostrum, we present a generalized framework for clinical and …

Background The clinical context for using blood eosinophil (EOS) counts as treatment–
response biomarkers in asthma and COPD requires better understanding of EOS …

Several biomarkers have been used to assess sputum eosinophilia in asthma. It has been
suggested that the diagnostic accuracy of these biomarkers might differ between asthma …

Background Previous cluster analyses on asthma are based on cross-sectional data.
Objective To identify phenotypes of adult-onset asthma by using data from baseline …

Background Adult-onset asthma is an important but relatively understudied asthma
phenotype and little is known about its natural course and prognosis. The remission rate is …

Despite access to diagnostic tests and effective therapies, asthma often remains
misdiagnosed and/or poorly controlled or uncontrolled. In this review, we address the key …

Several current guidelines/strategies outline a treatment approach to asthma, which
primarily consider the goals of improving lung function and quality of life and reducing …

Background Child-onset asthma is known to remit with high probability, but remission in
adult-onset asthma is seemingly less frequent. Reports of the association between …

Objective: The large amount of evidence and the renewed interest in upper and lower
airways involvement in infectious and inflammatory diseases has led Interasma (Global …